List of Tables
Table 1. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Extraction Injection
Table 3. Key Players of Precharge Injection
Table 4. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2020-2025)
Table 8. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2026-2031)
Table 10. Anti–vascular Endothelial Growth Factor Therapy Market Trends
Table 11. Anti–vascular Endothelial Growth Factor Therapy Market Drivers
Table 12. Anti–vascular Endothelial Growth Factor Therapy Market Challenges
Table 13. Anti–vascular Endothelial Growth Factor Therapy Market Restraints
Table 14. Global Anti–vascular Endothelial Growth Factor Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Players (2020-2025)
Table 16. Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti–vascular Endothelial Growth Factor Therapy as of 2024)
Table 17. Ranking of Global Top Anti–vascular Endothelial Growth Factor Therapy Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Anti–vascular Endothelial Growth Factor Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Anti–vascular Endothelial Growth Factor Therapy, Headquarters and Area Served
Table 20. Global Key Players of Anti–vascular Endothelial Growth Factor Therapy, Product and Application
Table 21. Global Key Players of Anti–vascular Endothelial Growth Factor Therapy, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2020-2025)
Table 25. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Type (2026-2031)
Table 27. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2020-2025)
Table 29. Global Anti–vascular Endothelial Growth Factor Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Anti–vascular Endothelial Growth Factor Therapy Revenue Market Share by Application (2026-2031)
Table 31. North America Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 46. Regeneron Pharmaceuticals (Eylea) Company Details
Table 47. Regeneron Pharmaceuticals (Eylea) Business Overview
Table 48. Regeneron Pharmaceuticals (Eylea) Anti–vascular Endothelial Growth Factor Therapy Product
Table 49. Regeneron Pharmaceuticals (Eylea) Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2020-2025) & (US$ Million)
Table 50. Regeneron Pharmaceuticals (Eylea) Recent Development
Table 51. Genentech Company Details
Table 52. Genentech Business Overview
Table 53. Genentech Anti–vascular Endothelial Growth Factor Therapy Product
Table 54. Genentech Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2020-2025) & (US$ Million)
Table 55. Genentech Recent Development
Table 56. Kanghong Pharmaceutical Company Details
Table 57. Kanghong Pharmaceutical Business Overview
Table 58. Kanghong Pharmaceutical Anti–vascular Endothelial Growth Factor Therapy Product
Table 59. Kanghong Pharmaceutical Revenue in Anti–vascular Endothelial Growth Factor Therapy Business (2020-2025) & (US$ Million)
Table 60. Kanghong Pharmaceutical Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
Table 64. Authors List of This Report
List of Figures
Figure 1. Anti–vascular Endothelial Growth Factor Therapy Picture
Figure 2. Global Anti–vascular Endothelial Growth Factor Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Type: 2024 VS 2031
Figure 4. Extraction Injection Features
Figure 5. Precharge Injection Features
Figure 6. Global Anti–vascular Endothelial Growth Factor Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Application: 2024 VS 2031
Figure 8. Macular Degeneration Case Studies
Figure 9. Nacular Edema Case Studies
Figure 10. Uveitis Case Studies
Figure 11. Retinal Vein Occlusion Case Studies
Figure 12. Anti–vascular Endothelial Growth Factor Therapy Report Years Considered
Figure 13. Global Anti–vascular Endothelial Growth Factor Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Anti–vascular Endothelial Growth Factor Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Region: 2024 VS 2031
Figure 16. Global Anti–vascular Endothelial Growth Factor Therapy Market Share by Players in 2024
Figure 17. Global Top Anti–vascular Endothelial Growth Factor Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti–vascular Endothelial Growth Factor Therapy as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Anti–vascular Endothelial Growth Factor Therapy Revenue in 2024
Figure 19. North America Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2020-2031)
Figure 21. United States Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2020-2031)
Figure 25. Germany Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Anti–vascular Endothelial Growth Factor Therapy Market Share by Region (2020-2031)
Figure 33. China Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2020-2031)
Figure 41. Mexico Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Anti–vascular Endothelial Growth Factor Therapy Market Share by Country (2020-2031)
Figure 45. Turkey Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Anti–vascular Endothelial Growth Factor Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Regeneron Pharmaceuticals (Eylea) Revenue Growth Rate in Anti–vascular Endothelial Growth Factor Therapy Business (2020-2025)
Figure 49. Genentech Revenue Growth Rate in Anti–vascular Endothelial Growth Factor Therapy Business (2020-2025)
Figure 50. Kanghong Pharmaceutical Revenue Growth Rate in Anti–vascular Endothelial Growth Factor Therapy Business (2020-2025)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
